Advertisement
Screener

SIGHT SCIENCES, INC. (SGHT) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Sight Sciences, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Sight Sciences, Inc. price/book ratio for the quarter ending 2026-06-30 was 5.6, a 81.89% increase year-over-year.
  • Sight Sciences, Inc. price/book ratio for the quarter ending 2026-03-31 was 3.78, a 137.92% increase year-over-year.
  • Sight Sciences, Inc. price/book ratio for the quarter ending 2025-12-31 was 6.63, a 213.16% increase year-over-year.
  • Sight Sciences, Inc. price/book ratio for the quarter ending 2025-09-30 was 2.8, a 16.27% decline year-over-year.
  • Sight Sciences, Inc. price/book ratio for fiscal 2026 was 5.6.
  • Sight Sciences, Inc. price/book ratio for fiscal 2025 was 6.63, a 213.16% increase from fiscal 2024.
  • Sight Sciences, Inc. price/book ratio for fiscal 2024 was 2.12, a 0.45% increase from fiscal 2023.
  • Sight Sciences, Inc. price/book ratio for fiscal 2023 was 2.11, a 42.76% decline from fiscal 2022.
Available history
2021-09-30 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-305.6$296.02M$52.89M
2026-03-313.78$203.71M$53.9M
2025-12-316.63$424.21M$63.94M
2025-09-302.8$179.99M$64.29M
2025-06-303.08$215.42M$70.01M
2025-03-311.59$123.3M$77.63M
2024-12-312.12$185.41M$87.52M
2024-09-303.34$317.51M$94.96M
2024-06-303.29$334.41M$101.64M
2024-03-312.4$261.7M$109.21M
2023-12-312.11$253.52M$120.22M
2023-09-301.28$162.76M$127.07M
2023-06-302.96$402.82M$136.13M
2023-03-312.89$423.46M$146.38M
2022-12-313.68$589.72M$160.08M
2022-09-301.77$305.33M$172.94M
2022-06-302.24$429.9M$191.76M
2022-03-312.6$550.14M$211.91M
2021-12-313.6$834.66M$232.11M
2021-09-30-4.36$1.07B-$245.98M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-305.6$296.02M$52.89M
2025-12-316.63$424.21M$63.94M
2024-12-312.12$185.41M$87.52M
2023-12-312.11$253.52M$120.22M
2022-12-313.68$589.72M$160.08M
2021-12-313.6$834.66M$232.11M

Similar stocks

Stock NameCountryMarket CapPE Ratio
NeuroPace Inc (NPCE)United States$0.480B-28.52
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39